Covered recipient · General Payments record
CHRISTINE C KENT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$627.11
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $627.11 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $290.80 | 12 |
| Novo Nordisk AS | $190.02 | 10 |
| Lilly USA, LLC | $83.83 | 5 |
| Acerta Pharma LLC | $31.69 | 2 |
| Abbott Laboratories | $30.77 | 2 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $627.11 | 31 |
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.68 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125378925 | CMS |
| Abbott Laboratories | $17.09 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125378928 | CMS |
| ABBVIE INC. | $24.83 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453572 | CMS |
| ABBVIE INC. | $7.48 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453574 | CMS |
| ABBVIE INC. | $22.63 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453576 | CMS |
| ABBVIE INC. | $3.51 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453578 | CMS |
| ABBVIE INC. | $6.23 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453580 | CMS |
| ABBVIE INC. | $3.91 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453582 | CMS |
| ABBVIE INC. | $20.62 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453584 | CMS |
| ABBVIE INC. | $6.44 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453586 | CMS |
| ABBVIE INC. | $14.44 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453588 | CMS |
| ABBVIE INC. | $124.83 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453590 | CMS |
| ABBVIE INC. | $29.30 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453592 | CMS |
| ABBVIE INC. | $26.58 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107453594 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.36 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105639250 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.33 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105594323 | CMS |
| Lilly USA, LLC | $19.70 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135601605 | CMS |
| Lilly USA, LLC | $16.97 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135589051 | CMS |
| Lilly USA, LLC | $15.13 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135545563 | CMS |
| Lilly USA, LLC | $15.09 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135595624 | CMS |
| Lilly USA, LLC | $16.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135626449 | CMS |
| Novo Nordisk Inc | $21.91 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100343894 | CMS |
| Novo Nordisk Inc | $20.18 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100303293 | CMS |
| Novo Nordisk Inc | $20.70 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575824 | CMS |
| Novo Nordisk Inc | $21.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100283392 | CMS |
| Novo Nordisk Inc | $17.70 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100342282 | CMS |
| Novo Nordisk Inc | $19.67 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100607210 | CMS |
| Novo Nordisk Inc | $18.71 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100415483 | CMS |
| Novo Nordisk Inc | $17.10 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100596853 | CMS |
| Novo Nordisk Inc | $21.82 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100621924 | CMS |
| Novo Nordisk Inc | $10.62 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100451166 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.